Stempeutics concludes patient enrollment for Phase 3 cell therapy trial for diabetic foot ulcer
Cipla has in-licensed Stempeucel-DFU product for Sales & Marketing in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Diabetic Foot Ulcer
Centaur Pharma to start post-marketing surveillance study of diabetic drug by end of January 2021
The company, with permission to conduct the PMS study in 200 to 500 patients with diabetic foot ulcers, plans to enrol them from…
Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer
Under this agreement, Cipla will get the exclusive marketing rights for five years in India for DFU product with Stempeutics…